The MTNAP1 Knockout HAP1 Polyclonal Cells product comprises a polyclonal population of HAP1 cells engineered via CRISPR/Cas9-mediated disruption of the MTNAP1 gene. This polyclonal knockout cell pool enables loss-of-function studies of MTNAP1, a critical factor in mitochondrial nucleoid organization and mtDNA maintenance. The product is supplied as a heterogeneous population of edited cells, reflecting a range of CRISPR-induced gene disruptions, and is suitable for applications that do not require clonal homogeneity. Researchers can interrogate the consequences of MTNAP1 depletion on mitochondrial DNA dynamics and respiratory function using this robust cellular model.
The host cell line, HAP1, is a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia line. Its haploid karyotype simplifies genetic manipulation, as a single targeting event can result in a functional knockout, increasing the efficiency of CRISPR/Cas9 editing. HAP1 cells retain many features of the parental leukemia line and are widely adopted in genetic screening and functional genomics studies. Their rapid growth, ease of culture, and genetic tractability make them an ideal background for investigating mitochondrial gene disruptions, where the interplay between nuclear and mitochondrial genomes is fundamental.
MTNAP1 is a mitochondrial nucleoid-associated protein that directly binds mtDNA and regulates its compaction and segregation. Mechanistically, MTNAP1 functions downstream of key mitochondrial biogenesis regulators such as PGC-1?? (PPARGC1A), NRF1, and TFAM. It interacts with core nucleoid components including TFAM, POLG, Twinkle (TWNK), and mtSSB, as well as ATAD3A, to maintain nucleoid architecture. Disruption of MTNAP1 impairs mtDNA replication and transcription, leading to diminished expression of mitochondrial-encoded oxidative phosphorylation subunits like MT-ND1 and MT-CO1, and ultimately compromises cellular respiratory capacity. This positions MTNAP1 as a linchpin in the signaling network that couples mitochondrial gene expression to metabolic demand.
In the HAP1 context, knockout of MTNAP1 provides a clean loss-of-function model due to the absence of a wild-type allele, eliminating compensation issues common in diploid cells. The leukemia origin of HAP1 cells further renders this model particularly relevant for studying mitochondrial dysfunction in cancer metabolism, where alterations in mtDNA maintenance and oxidative phosphorylation are increasingly recognized as therapeutic vulnerabilities. Moreover, the polyclonal nature of the knockout population allows for the observation of diverse phenotypic outcomes, mirroring the heterogeneity often encountered in tumor cell populations and facilitating the identification of robust, population-level effects on nucleoid dynamics and bioenergetics.
This knockout cell model is ideally suited for a broad range of research applications, including investigation of mitochondrial DNA maintenance, nucleoid architecture, and the role of mitochondrial dysfunction in disease. Representative assays include western blotting for mtDNA-encoded proteins, RT-qPCR for mtDNA transcripts, mtDNA copy number determination via qPCR, and Seahorse metabolic flux analysis to assess respiratory function. It can be employed in immunofluorescence studies of nucleoid morphology and flow cytometry-based measurements of mitochondrial mass. Furthermore, the polyclonal population is valuable for screening mitochondrial modulators and dissecting protein interactions within nucleoids via co-immunoprecipitation. For further technical information, please contact Ascent Research.
